Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 2
1987 3
1988 1
1989 1
1990 32
1991 3
1993 1
1995 1
1996 1
1997 1
2000 3
2002 1
2008 2
2011 2
2012 1
2014 2
2016 1
2017 3
2018 1
2019 5
2020 3
2021 1
2022 1
2023 2
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

73 results

Results by year

Filters applied: . Clear all
Page 1
An unnatural biopolymer.
Cho CY, Moran EJ, Cherry SR, Stephans JC, Fodor SP, Adams CL, Sundaram A, Jacobs JW, Schultz PG. Cho CY, et al. Among authors: moran ej. Science. 1993 Sep 3;261(5126):1303-5. doi: 10.1126/science.7689747. Science. 1993. PMID: 7689747
Novel biopolymers for drug discovery.
Moran EJ, Wilson TE, Cho CY, Cherry SR, Schultz PG. Moran EJ, et al. Biopolymers. 1995;37(3):213-9. doi: 10.1002/bip.360370305. Biopolymers. 1995. PMID: 7718743
Exploring the positional attachment of glycopeptide/beta-lactam heterodimers.
Long DD, Aggen JB, Chinn J, Choi SK, Christensen BG, Fatheree PR, Green D, Hegde SS, Judice JK, Kaniga K, Krause KM, Leadbetter M, Linsell MS, Marquess DG, Moran EJ, Nodwell MB, Pace JL, Trapp SG, Turner SD. Long DD, et al. Among authors: moran ej. J Antibiot (Tokyo). 2008 Oct;61(10):603-14. doi: 10.1038/ja.2008.80. J Antibiot (Tokyo). 2008. PMID: 19168974
A phase 2 multiple ascending dose study of the inhaled pan-JAK inhibitor nezulcitinib (TD-0903) in severe COVID-19.
Singh D, Bogus M, Moskalenko V, Lord R, Moran EJ, Crater GD, Bourdet DL, Pfeifer ND, Woo J, Kaufman E, Lombardi DA, Weng EY, Nguyen T, Woodcock A, Haumann B, Saggar R. Singh D, et al. Among authors: moran ej. Eur Respir J. 2021 Oct 14;58(4):2100673. doi: 10.1183/13993003.00673-2021. Print 2021 Oct. Eur Respir J. 2021. PMID: 34210790 Free PMC article. Clinical Trial.
Efficacy and safety of an inhaled pan-Janus kinase inhibitor, nezulcitinib, in hospitalised patients with COVID-19: results from a phase 2 clinical trial.
Belperio J, Nguyen T, Lombardi DA, Bogus M, Moskalenko V, Singh D, Haumann B, Bourdet DL, Kaufman E, Pfeifer ND, Thompson CG, Woo J, Moran EJ, Saggar R. Belperio J, et al. Among authors: moran ej. BMJ Open Respir Res. 2023 Jul;10(1):e001627. doi: 10.1136/bmjresp-2023-001627. BMJ Open Respir Res. 2023. PMID: 37460276 Free PMC article. Clinical Trial.
Wastewater surveillance provides 10-days forecasting of COVID-19 hospitalizations superior to cases and test positivity: A prediction study.
Hill DT, Alazawi MA, Moran EJ, Bennett LJ, Bradley I, Collins MB, Gobler CJ, Green H, Insaf TZ, Kmush B, Neigel D, Raymond S, Wang M, Ye Y, Larsen DA. Hill DT, et al. Among authors: moran ej. Infect Dis Model. 2023 Oct 31;8(4):1138-1150. doi: 10.1016/j.idm.2023.10.004. eCollection 2023 Dec. Infect Dis Model. 2023. PMID: 38023490 Free PMC article.
73 results